Skip to content

Clinical trials

Completed Neuroectodermal Tumors trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuroectodermal Tumors Status: Completed Country / region: United States Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20102
20141
20151
20162
20172

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)3
DNAtrix, Inc.2
BeiGene USA, Inc.1
Boehringer Ingelheim1
Gradalis, Inc.1
Hoffmann-La Roche1
M.D. Anderson Cancer Center1
University of Florida1
Yale University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuroectodermal Tumors12
Brain Neoplasms5
Neoplasms5
Neoplasms by Histologic Type4
Neoplasms, Nerve Tissue4
Sarcoma4
Sarcoma, Ewing4
Glioblastoma3
Gliosarcoma3
Neoplasms by Site3

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.